A Phase I Trial to Investigate the Metabolism and Pharmacokinetics of an Open-label Single Dose of 400 mg [14C]BI 671800 HEA Administered as an Oral Solution of the Choline Salt in Healthy Male Volunteers.
Phase of Trial: Phase I
Latest Information Update: 31 Oct 2013
At a glance
- Drugs BI 671800 (Primary)
- Indications Asthma; Seasonal allergic rhinitis
- Focus Pharmacokinetics
- Sponsors Boehringer Ingelheim Pharmaceuticals
- 18 Oct 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 28 Sep 2010 New trial record
- 22 Sep 2010 Status changed from not yet recruiting to recruiting according to clinicaltrials.gov.